[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357069-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357069-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrating-single-cell-multi-omics-and-machine-learning-to-reveal-triaptosis-heterogeneity-in-clear-cell-renal-cell-carcinoma","Integrating single-cell multi-omics and machine learning to reveal triaptosis heterogeneity in clear cell renal cell carcinoma","","Triaptosis, an emerging programmed cell death mode, remains insufficiently defined regarding intra-tumor heterogeneity in clear cell renal cell carcinoma (ccRCC). Using single-cell transcriptomics, the study maps triaptosis activity across cell types, highlighting monocytes and macrophages with the highest activity that further rises during terminal differentiation. These high-activity cells show stronger pro-angiogenic signaling to endothelial cells; epithelial late-differentiation subpopulations drive additional ccRCC associations. Spatial analysis shows triaptosis activity decreases with distance from the tumor epithelial core, and the top-activity epithelial cluster exhibits reduced metabolism.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-single-cell-multi-omics-and-machine-learning-to-reveal-triaptosis-heterogeneity-in-clear-cell-renal-cell-carcinoma/357069/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-single-cell-multi-omics-and-machine-learning-to-reveal-triaptosis-heterogeneity-in-clear-cell-renal-cell-carcinoma/357069.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study analyze in clear cell renal cell carcinoma?","Question",{"text":63,"@type":64},"It characterizes triaptosis heterogeneity within ccRCC, mapping triaptosis activity across single-cell populations and relating activity to differentiation and tumor traits.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cell types show the highest triaptosis activity?",{"text":68,"@type":64},"Monocytes and macrophages exhibit the highest triaptosis activity, with activity increasing upon terminal differentiation.",{"name":70,"@type":61,"acceptedAnswer":71},"How is prognosis and treatment guidance addressed?",{"text":72,"@type":64},"The work develops a four-gene prognostic signature from high-triaptosis epithelial subpopulations and reports its performance for prognostic stratification, immunotherapy guidance, and chemotherapy response prediction, also proposing candidate molecularly targeted therapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357069,1790801408,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Dai etal. Human Genomics (2026) 20:93 Human Genomics  \n[https://doi.org/10.1186/s40246-026-00982-3](https://doi.org/10.1186/s40246-026-00982-3)  \nRESEARCH Open Access  \nIntegrating single-cell multi-omicsand machine learning to reveal triaptosis heterogeneity in clear cell renal cell carcinoma  \nHaojie Dai1,2†, Renjun Lu1,2,3†, Mingcong Zhang4†, Zhenyu Hang1, Ke Jiang1, Chao Qin1,2,3* and You Zhao1*  \nAbstract  \nTriaptosis, an emerging form of cell death, remains poorly characterized in terms of its heterogeneity within  \nclear cell renal cell carcinoma (ccRCC) . Utilizing single-cell transcriptomics, we delineate a landscape of triaptosis heterogeneity and identify monocytes and macrophages as exhibiting the highest triaptosis activity, which further increases upon terminal differentiation. These high-activity cells also demonstrate enhanced pro-angiogenic signaling toward endothelial cells. Within epithelial cells, subpopulations with the strongest triaptosis activity are located at the late differentiation stage and are closely associated with ccRCC traits. Spatial transcriptomic analysis reveals a decline in triaptosis activity with increasing distance from the tumor epithelial core. The epithelial cluster with the highest triaptosis activity showed reduced metabolic activity. In bulk transcriptome analysis, patients with high epithelial triaptosis activity infiltration exhibited improved prognosis, broader immune activation, and similarly suppressed metabolism. We subsequently developed a robust 4-gene prognostic signature based on module genes derived from high-triaptosis epithelial subpopulations. This model showed strong performance in prognostic stratification, immunotherapy guidance, and chemotherapy response prediction. Finally, we identified SLC25A37 as a core oncogenic gene within the signature and proposed Yohimbic acid among several potential molecularly targeted therapeutics.  \nKeywords Triaptosis, Clear cell renal cell carcinoma, Single cell, Prognosis  \n†Haojie Dai, Renjun Lu and Mingcong Zhang have contributed equally to this work.  \n*Correspondence: Chao Qin [Qinc_uro@163.com](Qinc_uro@163.com)[ ](Qinc_uro@163.com)You Zhao  \n[zhaoyou0183@163.com](zhaoyou0183@163.com)  \n1The Affiliated Liyang People’s Hospital of Kangda College of Nanjing Medical University, Liyang Branch Hospital of Jiangsu Province Hospital, Liyang, Changzhou, Jiangsu, China  \n2The First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China  \n3Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China 4Department of Urology, The Second People’s Hospital of Lianyungang, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang, Jiangsu, China  \nIntroduction  \nRenal cell carcinoma (RCC) accounts for nearly 500,000 new cases each year worldwide [1], making it the sixth most commonly diagnosed cancer globally [2]. The clear cell subtype (ccRCC) represents the predominant form of RCC, comprising more than 70% of all cases [1]. While localized disease is associated with favorable outcomes, with 5-year survival rates approaching 95%[3], significant clinical challenges remain due to the marked clinicopathological heterogeneity of the disease [4]. Notably, metastases are either detected at initial diagnosis or develop during follow-up in approximately 30% of ccRCC patients [5], leading to poor prognosis and 5-year survival rates of less than 10%[6]. Thus, there is a pressing  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission und","cbCaip8jluYNGaH3","https://ap.wps.com/l/cbCaip8jluYNGaH3","pdf",8447147,22,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What does the study analyze in clear cell renal cell carcinoma?\",\"answer\":\"It characterizes triaptosis heterogeneity within ccRCC, mapping triaptosis activity across single-cell populations and relating activity to differentiation and tumor traits.\"},{\"question\":\"Which cell types show the highest triaptosis activity?\",\"answer\":\"Monocytes and macrophages exhibit the highest triaptosis activity, with activity increasing upon terminal differentiation.\"},{\"question\":\"How is prognosis and treatment guidance addressed?\",\"answer\":\"The work develops a four-gene prognostic signature from high-triaptosis epithelial subpopulations and reports its performance for prognostic stratification, immunotherapy guidance, and chemotherapy response prediction, also proposing candidate molecularly targeted therapy.\"}]","Integrating single-cell multi-omics and machine learning to reveal triaptosis heterogeneity in clear cell renal cell carcinoma | PDF",1790128811,55,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82b6170eb9a1c0b7ad07a5c14d153727.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1896f120213745a7841680802187d61.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6760a3f6dc207955f8af53f6338adebe.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/101b9cdad3af966d40950d41d39df752.webp",980,1306]